At this point in time, the committee was of the opinion that the benefits of Mycograb in the treatment of invasive candidiasis did not outweigh its risks. ###>À ce stade, le comité a estimé que les effets bénéfiques de Mycograb dans le traitement de la candidose invasive ne l’ emportaient pas sur les risques.